Go Pro

Reckitt Benckiser Group (LON:RKT) Announces Earnings Results

Reckitt Benckiser Group logo with Consumer Defensive background
Image from MarketBeat Media, LLC.

Key Points

  • Reckitt Benckiser Group reported quarterly earnings of GBX 147.08 per share, with a net margin of 22.40% and return on equity of 45.27%.
  • The stock was trading around GBX 4,995, giving the company a market cap of £31.72 billion and a PE ratio of 10.26. Its debt-to-equity ratio remains elevated at 108.83.
  • Analysts currently have a cautious outlook on the shares, with a consensus rating of Hold and an average price target of GBX 6,204.29. Three analysts rate it a Buy, while four rate it Hold.
  • Five stocks we like better than Reckitt Benckiser Group.

Reckitt Benckiser Group (LON:RKT - Get Free Report) announced its earnings results on Friday. The company reported GBX 147.08 earnings per share for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a net margin of 22.40% and a return on equity of 45.27%.

Reckitt Benckiser Group Trading Down 0.0%

LON:RKT opened at GBX 4,995 on Friday. The company has a debt-to-equity ratio of 108.83, a current ratio of 0.85 and a quick ratio of 0.46. The firm has a 50-day moving average of GBX 4,706.82 and a 200-day moving average of GBX 5,378.55. The company has a market cap of £31.72 billion, a PE ratio of 10.26, a PEG ratio of 1.10 and a beta of 0.25. Reckitt Benckiser Group has a one year low of GBX 3,866 and a one year high of GBX 6,522.92.

Insider Buying and Selling

In related news, insider Shannon Eisenhardt acquired 432 shares of the stock in a transaction dated Friday, June 12th. The stock was purchased at an average cost of £432 per share, with a total value of £186,624. Also, insider Marybeth Hays bought 340 shares of the business's stock in a transaction that occurred on Monday, June 1st. The shares were bought at an average cost of GBX 4,585 per share, for a total transaction of £15,589. Over the last quarter, insiders bought 1,029 shares of company stock valued at $21,416,350. Company insiders own 0.44% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently commented on RKT. Berenberg Bank cut their target price on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a "buy" rating on the stock in a research report on Friday, April 24th. Jefferies Financial Group reiterated a "hold" rating and issued a GBX 5,600 target price on shares of Reckitt Benckiser Group in a report on Tuesday, June 16th. Deutsche Bank Aktiengesellschaft dropped their price target on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a "hold" rating on the stock in a research note on Tuesday, April 28th. Royal Bank Of Canada restated a "neutral" rating and set a GBX 6,200 price target on shares of Reckitt Benckiser Group in a report on Friday, May 15th. Finally, Citigroup reduced their price objective on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a "buy" rating for the company in a research report on Thursday, April 23rd. Three research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, Reckitt Benckiser Group currently has an average rating of "Hold" and a consensus target price of GBX 6,204.29.

Read Our Latest Research Report on Reckitt Benckiser Group

Reckitt Benckiser Group Company Profile

(Get Free Report)

At Reckitt, we protect, heal and nurture. We are the company behind some of the world's best known and most trusted Health and Hygiene consumer brands. Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years. We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide. At Reckitt, we're all making a real difference to people all over the world, every day.

Further Reading

Should You Invest $1,000 in Reckitt Benckiser Group Right Now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines